Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular Signature for Receptor Engagement in the Metabolic Peptide Hormone Amylin
Rebekah L. Bower, Lauren R. Yule, Tayla A. Rees, et al.
ACS Pharmacology & Translational Science (2018) Vol. 1, Iss. 1, pp. 32-49
Open Access | Times Cited: 65

Showing 1-25 of 65 citing articles:

Cryo-EM structure of the active, Gs-protein complexed, human CGRP receptor
Yi-Lynn Liang, Maryam Khoshouei, Giuseppe Deganutti, et al.
Nature (2018) Vol. 561, Iss. 7724, pp. 492-497
Open Access | Times Cited: 233
CGRP physiology, pharmacology, and therapeutic targets: migraine and beyond
Andrew F. Russo, Debbie L. Hay
Physiological Reviews (2022) Vol. 103, Iss. 2, pp. 1565-1644
Open Access | Times Cited: 162
Shared and independent roles of CGRP and PACAP in migraine pathophysiology
Adisa Kuburas, Andrew F. Russo
The Journal of Headache and Pain (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 49
Development of Cagrilintide, a Long-Acting Amylin Analogue
Thomas Kruse, Jakob Lerche Hansen, Kirsten Dahl, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 15, pp. 11183-11194
Open Access | Times Cited: 67
A structural basis for amylin receptor phenotype
Jianjun Cao, Matthew J. Belousoff, Yi-Lynn Liang, et al.
Science (2022) Vol. 375, Iss. 6587
Closed Access | Times Cited: 48
Diabetes and its Complications
Simon Matoori
ACS Pharmacology & Translational Science (2022) Vol. 5, Iss. 8, pp. 513-515
Open Access | Times Cited: 32
Distinct Patterns of Internalization of Different Calcitonin Gene-Related Peptide Receptors
Joseph J. Gingell, Tayla A. Rees, Erica R. Hendrikse, et al.
ACS Pharmacology & Translational Science (2020) Vol. 3, Iss. 2, pp. 296-304
Open Access | Times Cited: 49
Antagonism of CGRP Signaling by Rimegepant at Two Receptors
Kylie S. Pan, Andrew Siow, Debbie L. Hay, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 47
RAMPs as allosteric modulators of the calcitonin and calcitonin-like class B G protein-coupled receptors
Augen A. Pioszak, Debbie L. Hay
Advances in pharmacology (2020), pp. 115-141
Open Access | Times Cited: 40
CGRP receptor antagonists for migraine. Are they also AMY1 receptor antagonists?
Michael L. Garelja, Christopher S. Walker, Debbie L. Hay
British Journal of Pharmacology (2021) Vol. 179, Iss. 3, pp. 454-459
Open Access | Times Cited: 34
Elucidating the Interactome of G Protein-Coupled Receptors and Receptor Activity-Modifying Proteins
Ilana B. Kotliar, Emily Lorenzen, Jochen M. Schwenk, et al.
Pharmacological Reviews (2022) Vol. 75, Iss. 1, pp. 1-34
Open Access | Times Cited: 28
New Insights into the Regulation of CGRP-Family Receptors
Joseph J. Gingell, Erica R. Hendrikse, Debbie L. Hay
Trends in Pharmacological Sciences (2018) Vol. 40, Iss. 1, pp. 71-83
Closed Access | Times Cited: 41
A Supervised Molecular Dynamics Approach to Unbiased Ligand–Protein Unbinding
Giuseppe Deganutti, Stefano Moro, Christopher A. Reynolds
Journal of Chemical Information and Modeling (2020) Vol. 60, Iss. 3, pp. 1804-1817
Open Access | Times Cited: 38
β-Cell Death in Diabetes: Past Discoveries, Present Understanding, and Potential Future Advances
Noyonika Mukherjee, Li Lin, Christopher Contreras, et al.
Metabolites (2021) Vol. 11, Iss. 11, pp. 796-796
Open Access | Times Cited: 30
Characterisation of agonist signalling profiles and agonist‐dependent antagonism at PACAP‐responsive receptors: Implications for drug discovery
Zoe Tasma, Andrew Siow, Paul W. R. Harris, et al.
British Journal of Pharmacology (2021) Vol. 179, Iss. 3, pp. 435-453
Open Access | Times Cited: 29
Pharmacological characterisation of mouse calcitonin and calcitonin receptor‐like receptors reveals differences compared with human receptors
Michael L. Garelja, Rebekah L. Bower, Margaret A. Brimble, et al.
British Journal of Pharmacology (2021) Vol. 179, Iss. 3, pp. 416-434
Open Access | Times Cited: 28
CGRP and the Calcitonin Receptor are Co-Expressed in Mouse, Rat and Human Trigeminal Ganglia Neurons
Tayla A. Rees, Andrew F. Russo, Simon J. O’Carroll, et al.
Frontiers in Physiology (2022) Vol. 13
Open Access | Times Cited: 21
Structural Analysis of Amylin and Amyloid β Peptide Signaling in Alzheimer’s Disease
Lisi Xie, Christopher Lockhart, Steven R. Bowers, et al.
Biomolecules (2025) Vol. 15, Iss. 1, pp. 89-89
Open Access
Development and pharmacological characterization of novel multi‐ calcitonin gene‐related peptide and pituitary adenylate cyclase‐activating peptide receptor antagonists
Zoe Tasma, Andrew Siow, Paul W. R. Harris, et al.
Headache The Journal of Head and Face Pain (2025)
Open Access
Structural and dynamic features of cagrilintide binding to calcitonin and amylin receptors
Jianjun Cao, Matthew J. Belousoff, Rachel M. Johnson, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Where are we now? Biased signalling of Class B G protein-coupled receptor-targeted therapeutics
Zoe Tasma, Michael L. Garelja, Aqfan Jamaluddin, et al.
Pharmacology & Therapeutics (2025), pp. 108846-108846
Open Access
Hidden GPCR structural transitions addressed by multiple walker supervised molecular dynamics (mwSuMD)
Giuseppe Deganutti, Ludovico Pipitò, Roxana M. Rujan, et al.
(2025)
Open Access
Hidden GPCR structural transitions addressed by multiple walker supervised molecular dynamics (mwSuMD)
Giuseppe Deganutti, Ludovico Pipitò, Roxana‐Maria Rujan, et al.
eLife (2025) Vol. 13
Open Access
Molecular Mechanisms of Class B GPCR Activation: Insights from Adrenomedullin Receptors
Michael L. Garelja, Maggie Au, Margaret A. Brimble, et al.
ACS Pharmacology & Translational Science (2020) Vol. 3, Iss. 2, pp. 246-262
Open Access | Times Cited: 32
Pharmacological characterisation of erenumab, Aimovig, at two calcitonin gene‐related peptide responsive receptors
Michael L. Garelja, Tyla I. Alexander, Amy Bennie, et al.
British Journal of Pharmacology (2023) Vol. 181, Iss. 1, pp. 142-161
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top